Safety and Tolerability of Tirbanibulin 1% Treatment of Actinic Keratosis on Face and Scalp in Routine Clinical Practice Across the U.S. (PROAK Study). J of Skin 2023, 7 (6), s263. https://doi.org/10.25251/skin.7.supp.263.